XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash flows from operating activities:    
Net earnings $ 575.3 $ 459.5
Adjustments to reconcile net earnings to cash flows from operating activities:    
Depreciation and amortization of property, plant and equipment 29.2 25.1
Amortization of intangible assets 293.2 203.0
Amortization of deferred financing costs 6.8 4.3
Non-cash stock compensation 69.3 58.2
Gain on sale of assets, net of tax (21.6) 0.0
Income tax provision, excluding tax associated with gain on sale of assets 145.5 129.2
Changes in operating assets and liabilities, net of acquired businesses:    
Accounts receivable 60.7 49.6
Unbilled receivables (29.4) (42.3)
Inventories (14.7) (19.1)
Accounts payable and accrued liabilities 17.5 18.8
Deferred revenue 40.2 (4.3)
Cash tax paid for gain on disposal of businesses 0.0 (10.0)
Cash income taxes paid (151.3) (52.5)
Other, net (35.6) (6.5)
Cash provided by operating activities 985.1 813.0
Cash flows from (used in) investing activities:    
Acquisitions of businesses, net of cash acquired (15.5) (153.0)
Capital expenditures (17.2) (15.5)
Capitalized software expenditures (15.3) (5.2)
Proceeds from (used in) disposal of businesses (0.1) (3.8)
Proceeds from sale of assets 27.1 0.0
Other, net (1.2) 0.0
Cash used in investing activities (22.2) (177.5)
Cash flows from (used in) financing activities:    
Proceeds from senior notes 0.0 600.0
Borrowings (payments) under revolving line of credit, net (870.0) 0.0
Debt issuance costs 0.0 (12.0)
Cash dividends to stockholders (117.8) (106.6)
Proceeds from stock-based compensation, net 45.2 47.7
Treasury stock sales 8.2 4.5
Other (0.2) (0.7)
Cash flows provided by (used in) financing activities (934.6) 532.9
Effect of foreign currency exchange rate changes on cash 1.2 (7.3)
Net increase in cash and cash equivalents 29.5 1,161.1
Cash and cash equivalents, beginning of period 308.3 709.7
Cash and cash equivalents, end of period $ 337.8 $ 1,870.8